1 / 32

Factors Impacting Drug Dissolution and Absorption : Current State of Science

Factors Impacting Drug Dissolution and Absorption : Current State of Science. Lawrence X. Yu, Ph. D. Director for Science Office of Generic Drugs Food and Drug Administration. Advisory Committee for Pharmaceutical Science May 3, 2005. Presentation Outline. In Vitro Dissolution Testing

niveditha
Download Presentation

Factors Impacting Drug Dissolution and Absorption : Current State of Science

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Factors Impacting Drug Dissolution and Absorption: Current State of Science Lawrence X. Yu, Ph. D. Director for Science Office of Generic Drugs Food and Drug Administration Advisory Committee for Pharmaceutical Science May 3, 2005

  2. Presentation Outline • In Vitro Dissolution Testing • Limits to Oral Drug Absorption • Challenges to Regulatory Evaluation

  3. Oral Drug Absorption Gastric Emptying Metabolism Transit Permeation Dissolution

  4. × æ ö dX A D X d = = × - ç ÷ DR C s dt h V è ø What Does Dissolution Measure? Solid drug particle stagnant layer (h) with a concentration = Cs bulk solution with a concentration = Ct = Xd/V Bulk Solvent

  5. Quality Control: Pharmaceutical Solid Polymorphism Form II Form I

  6. 120 120 90 90 Regular Regular % Dissolved 60 Fast % Absorbed 60 Fast Slow Slow 30 30 0 0 0 5 10 15 20 25 0 5 10 15 20 25 30 Time (hrs.) Time (hrs.) In Vivo Bioequivalence: IVIVC Dissolution Profiles Fraction Absorption Profiles

  7. Presentation Outline • In Vitro Dissolution Testing • Limits to Oral Drug Absorption • Challenges to Regulatory Evaluation

  8. …… …..….. …….. Disintegration Dissolution What Affects Dissolution? Drug Substance Factors

  9. Gastric Emptying Metabolism Transit Permeation Solubility Dissolution Permeation Dissolution Conc  Solubility In Vivo and In Vitro Relationship: Scientific Issues • Limits to oral drug absorption • Dissolution-limited • Solubility-limited • Permeability-limited

  10. Quantitative Estimation of Absorption

  11. Limits to Oral Drug Absorption(Yu, Pharm. Res. 16:1884-1888 (1999))

  12. CAT Model: Extent of Intestinal Drug Absorption (Permeability-limited)(Yu et al. Int. J. Pharm. 186:119-125 (1999))

  13. Digoxin: Dissolution-limited (Yu, Pharm. Res. 16:1884-1888 (1999))

  14. Griseofulvin: Solubility-limited(Yu, Pharm. Res. 16:1884-1888 (1999))

  15. Applications of Predictive Absorption Model in Drug Discovery

  16. …… …..….. …….. Disintegration Dissolution What Affects Dissolution? Dosage Form Factors

  17. Plasma Concentration Profile of a Drug from an Oral Solution 14 12 10 8 Plasma Conc 6 4 2 Oral Solution Data Oral Solution Simulation 0 0 2 4 6 8 10 12 time (hr)

  18. 1 0.8 0.6 fraction dissolved 0.4 0.2 Slow Medium Fast 0 0 2 4 6 8 10 12 time (hr) Dissolution Profile from a Drug from A Solid Oral Dosage Form

  19. 9 Slow Medium 8 Fast 7 6 5 Plasma Conc 4 3 2 1 0 0 2 4 6 8 10 time (hr) Plasma Concentration Profile of a Drug from a Solid Oral Dosage Form

  20. 1 0.8 0.6 fraction dissolved 0.4 0.2 Slow Medium Fast 0 0 2 4 6 8 10 12 time (hr) Dissolution Profile of a Drug with Different Protective Coating

  21. PK Profile of a Drug with Different Protective Coating 0.05 Measured Slow Medium 0.04 Fast 0.03 Plasma Conc 0.02 0.01 0 0 5 10 15 20 time (hr)

  22. Presentation Outline • In Vitro Dissolution Testing • Limits to Oral Drug Absorption • Challenges to Regulatory Evaluation

  23. Dissolution and Limits to Oral Absorption • When dissolution is rapid and, therefore, not the rate determining step, drug levels in blood/plasma may not reflect dissolution differences • Dissolution-limited absorption • IVIVC possible for IR/ER products • In vivo fraction absorption profile is not always possible; Deconvolution-based IVIVC methods • Solubility-limited absorption • Permeability-limited absorption • Convolution-based IVIVC methods

  24. f2= ‘Similarity’ Factor. Values are scaled between 0-100. f2 values greater than 50 (50-100) reflect a 10% or less, ‘overall’ or ‘global’ difference between the two curves. 1 å - = · + - · 2 0 . 5 f 2 50 log {[ 1 ( ( R T ) ] 100 } t t n Dissolution Profile Comparison

  25. Dissolution testing is “non-discriminating” Dissolution - limited absorption Others Dissolution testing is “over discriminating” Solubility - limited absorption Permeability - limited absorption In Vitro and In Vivo “f2 values greater than 50 (50-100) ensure sameness or equivalence of the two curves and, thus, of the performance of the test (post -change) and reference (pre-change) products.”

  26. Role of Dissolution Testing • A quality control tool to monitor batch-to-batch consistency of the drug release from a product • An in vitro surrogate for product performance that can guide formulation development and ascertain the need for bioequivalence tests Are these goals consistent?

  27. Hydrodynamic Conditions • Current Paddle Speeds Result in Re: • Re = 4688 (50 RPM) • Re = 9375 (100 RPM) • Some evidence that current speeds are correlated with in vivo dissolution • Slower laminar flows would lead to much more reproducible hydrodynamics, but may not correlate with in vivo hydrodynamics. A. Scholz, E. Kostewicz, B. Abrahamsson and J. B. Dressman Can the USP paddle method be used to represent in-vivo hydrodynamics? Journal of Pharmacy and Pharmacology 55 (2003) 443-451

  28. Medium • Product Specific Medium • Allows full dissolution for all products in a finite time and dissolution volume • Universal/Biorelevant Media • A true in vivo correlation should use the same media for all products

  29. Role of Dissolution • Should the roles be separated? • Is single point acceptance criterion relevant for either role? • Do the multiple roles impede the reduction of variability?

  30. Dissolution for Quality Control • A product specific quality control test • The hydrodynamics and medium for this test are chosen for reproducibility and detection of product changes • The design of this test is not constrained by a desire to mimic in vivo conditions.

  31. Dissolution for In Vivo Performance • A biorelevant dissolution test • All products should undergo dissolution testing in the same device and same media (corresponding to stomach and intestine under fed and fasted conditions) that gives the best possibility to correlate with in vivo dissolution • The biorelevant dissolution test is a one-time test to provide a baseline for product performance • Any biowaivers should rely on the biorelevant dissolution testing • Biorelevant dissolution testing as a quality control test

  32. Summary • In Vitro Dissolution Testing - Over discriminating/Non-discriminating dissolution - Not sufficient to assure bioequivalence/bioavailability • Limits to Oral Drug Absorption - Dissolution/Solubility/Permeability-limited absorption • Challenges to Regulatory Evaluation • Dissolution Profile Comparison • Role of Dissolution Testing

More Related